DE19824230A1 - Neues Endometriose-assoziiertes Gen - Google Patents

Neues Endometriose-assoziiertes Gen

Info

Publication number
DE19824230A1
DE19824230A1 DE19824230A DE19824230A DE19824230A1 DE 19824230 A1 DE19824230 A1 DE 19824230A1 DE 19824230 A DE19824230 A DE 19824230A DE 19824230 A DE19824230 A DE 19824230A DE 19824230 A1 DE19824230 A1 DE 19824230A1
Authority
DE
Germany
Prior art keywords
nucleic acid
polypeptide
seq
composition according
nucleotide sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19824230A
Other languages
German (de)
English (en)
Inventor
Anna Starzinski-Powitz
Silvia Kotzian
Heike Handrow-Metzmacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STARZINSKI POWITZ ANNA
Original Assignee
STARZINSKI POWITZ ANNA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STARZINSKI POWITZ ANNA filed Critical STARZINSKI POWITZ ANNA
Priority to DE19824230A priority Critical patent/DE19824230A1/de
Priority to EP99927792A priority patent/EP1080195A1/de
Priority to AU45024/99A priority patent/AU765515B2/en
Priority to CA002329527A priority patent/CA2329527A1/en
Priority to PCT/EP1999/003716 priority patent/WO1999063079A1/de
Priority to CN99807965A priority patent/CN1307636A/zh
Priority to JP2000552274A priority patent/JP2002517193A/ja
Priority to NZ508439A priority patent/NZ508439A/xx
Publication of DE19824230A1 publication Critical patent/DE19824230A1/de
Priority to US09/725,311 priority patent/US6586569B1/en
Priority to US10/609,691 priority patent/US20080187527A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19824230A 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen Withdrawn DE19824230A1 (de)

Priority Applications (10)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen
CN99807965A CN1307636A (zh) 1998-05-29 1999-05-28 新的子宫内膜异位相关基因
AU45024/99A AU765515B2 (en) 1998-05-29 1999-05-28 Endometriosis-associated gene
CA002329527A CA2329527A1 (en) 1998-05-29 1999-05-28 Endometriosis-associated gene
PCT/EP1999/003716 WO1999063079A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen
EP99927792A EP1080195A1 (de) 1998-05-29 1999-05-28 Endometriose-assoziiertes gen
JP2000552274A JP2002517193A (ja) 1998-05-29 1999-05-28 子宮内膜症関連遺伝子
NZ508439A NZ508439A (en) 1998-05-29 1999-05-28 Novel endometriosis-associated gene
US09/725,311 US6586569B1 (en) 1998-05-29 2000-11-29 Endometriosis-associated gene
US10/609,691 US20080187527A1 (en) 1998-05-29 2003-07-01 Novel endometriosis-associated gene

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19824230A DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen

Publications (1)

Publication Number Publication Date
DE19824230A1 true DE19824230A1 (de) 1999-12-02

Family

ID=7869409

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19824230A Withdrawn DE19824230A1 (de) 1998-05-29 1998-05-29 Neues Endometriose-assoziiertes Gen

Country Status (9)

Country Link
US (1) US6586569B1 (enExample)
EP (1) EP1080195A1 (enExample)
JP (1) JP2002517193A (enExample)
CN (1) CN1307636A (enExample)
AU (1) AU765515B2 (enExample)
CA (1) CA2329527A1 (enExample)
DE (1) DE19824230A1 (enExample)
NZ (1) NZ508439A (enExample)
WO (1) WO1999063079A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
WO2001062959A3 (en) * 2000-02-25 2003-01-03 Procrea Biosciences Inc Endometriosis-related markers and uses thereof
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis
EP1801236A3 (en) * 2000-02-25 2007-10-10 Siemens Medical Solutions Diagnostics Endometriosis related markers and uses thereof

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777312B2 (en) * 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9353405B2 (en) 2002-03-12 2016-05-31 Enzo Life Sciences, Inc. Optimized real time nucleic acid detection processes
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
US11287425B2 (en) 2009-04-22 2022-03-29 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
CN112180099B (zh) * 2020-09-15 2022-07-29 江南大学附属医院 子宫内膜异位症血清标志物的应用
CN113512584B (zh) * 2021-06-24 2022-03-25 南京鼓楼医院 Pbk/topk在诊断和治疗薄型内膜疾病中的应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005268A1 (en) * 1992-09-04 1994-03-17 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
WO1995016466A1 (en) * 1993-12-17 1995-06-22 The Ohio State University Antisense oligonucleotides to suppress eicosanoid formation
WO1996040720A1 (en) * 1995-06-07 1996-12-19 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis
JP2001501300A (ja) * 1996-09-06 2001-01-30 オステオメーター・ビオテク・エー／エス ヒト子宮内膜の生化学的マーカー

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005268A1 (en) * 1992-09-04 1994-03-17 Baylor College Of Medicine Novel triplex forming oligonucleotides and methods for their use
WO1995016466A1 (en) * 1993-12-17 1995-06-22 The Ohio State University Antisense oligonucleotides to suppress eicosanoid formation
WO1996040720A1 (en) * 1995-06-07 1996-12-19 University Of Rochester Mammalian prostaglandin h synthase-2
DE19548122A1 (de) * 1995-12-21 1997-06-26 Joern Prof Dr Bullerdiek Nukleinsäuresequenzen von Genen der High Mobility Group Proteine sowie Verwendungen derselben

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
BIOSIS: Ref. 98:264048 *
Chemical Abstracts: Vol.128, 1998, Ref. 320180d *
EMBL, Ref. AL023586 *
MEDLINE: Ref. 97264341 *
Ref. 96207227 *
Ref. 97:414944 *
Vol.120, 1994, Ref. 103448c *
Vol.126, 1997, Ref. 184658v *
Vol.127, 1997, Ref. 107447u *
Vol.127, 1997, Ref. 203718d *
Vol.127, 1997, Ref. 277204e *
Vol.128, 1998, Ref. 317648g *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062959A3 (en) * 2000-02-25 2003-01-03 Procrea Biosciences Inc Endometriosis-related markers and uses thereof
US6777182B2 (en) * 2000-02-25 2004-08-17 Metriogene Biosciences Inc. Methods for determining the likelihood of endometriosis in a female subject
EP1801236A3 (en) * 2000-02-25 2007-10-10 Siemens Medical Solutions Diagnostics Endometriosis related markers and uses thereof
US8148061B2 (en) 2000-02-25 2012-04-03 Siemens Healthcare Diagnostics Inc. Endometriosis-related markers and uses thereof
US8541173B2 (en) 2000-02-25 2013-09-24 Siemens Healthcare Diagnostics Inc. Endometriosis-related markers and uses thereof
DE10048633A1 (de) * 2000-09-25 2002-04-18 Schering Ag Methode zur in vitro Diagnostik von Endometriose
US6780594B2 (en) 2000-09-25 2004-08-24 Schering Aktiengesellschaft Method for in vitro diagnosis of endometriosis

Also Published As

Publication number Publication date
US6586569B1 (en) 2003-07-01
US20030109018A1 (en) 2003-06-12
EP1080195A1 (de) 2001-03-07
CA2329527A1 (en) 1999-12-09
CN1307636A (zh) 2001-08-08
AU765515B2 (en) 2003-09-18
WO1999063079A1 (de) 1999-12-09
JP2002517193A (ja) 2002-06-18
AU4502499A (en) 1999-12-20
NZ508439A (en) 2004-02-27

Similar Documents

Publication Publication Date Title
DE3752360T2 (de) Menschliche DNS zum Nachweis von Retinoblastoma
DE69131044T2 (de) Interleukin-i antagonist und seine verwendung
DE19824230A1 (de) Neues Endometriose-assoziiertes Gen
EP1923465A1 (de) Inhibitor-Protein des WNT-Signalwegs
DE69635349T2 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
DE60214867T2 (de) Histonedeacetylase 9
DE69424209T2 (de) Tumorsuppressor-Gen Merlin und dessen Verwendungen
DE69433915T2 (de) MDC-Proteine und dafür kodierende DNS
EP1588172A2 (de) Verfahren zur identifizierung bhs-spezifischer proteine und fragmente davon
EP0805204B1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
EP1453531A2 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
DE60117788T2 (de) Menschliche wingless-ähnliche gene
EP1007671B1 (de) Fanconi-gen ii
DE19521046C1 (de) Protein mit DNase-Aktivität
EP1220921B1 (de) Nukleinsäuresequenzen von hyperplasien und tumoren der schilddrüse
DE69737570T2 (de) Agentien zur präsymptomatischen Detektion, Prävention und Behandlung von Brustkrebs in Menschen
EP0820511A1 (de) Sonde zur früherkennung von epithelialen dysplasien des mehrschichtigen plattenepithels sowie zur tumordiagnostik und tumortherapie
EP0620851A1 (de) Neuroblastom-assoziiertes regulator-gen.
DE69519654T2 (de) htFIIIA Gen
DE69519715T2 (de) PRLTS-Proteine und die dafür kodierende DNA
DE19958680A1 (de) cDNA-Sequenzen von zwei Interaktoren FANCIP4 und FANCIP5 der Fanconi-Anämie-Pr oteine der Komplementationsgruppen A und C
EP1162265A2 (de) Humanes PEM als Target für die Fertilitätskontrolle und die Alzheimertherapie
EP0939813A1 (de) Mammakarzinom-assoziiertes gen
DE4344397A1 (de) Humanes zirkulierendes Cytokin CC-1
DE19904650A1 (de) cDNA-Sequenz eines Interaktors FANCIP1 des Fanconi-Anämie-Proteins der Komplementationsgruppe A

Legal Events

Date Code Title Description
OM8 Search report available as to paragraph 43 lit. 1 sentence 1 patent law
8139 Disposal/non-payment of the annual fee